| Primary information |
|---|
| sequence ID | Seq_591 |
| Peptide sequence | ALYAQARAK |
| CancerPDF_ID | CancerPDF_ID1768, CancerPDF_ID11241, |
| PMID | 21136997,26992070 |
| Protein Name | Inter-alpha-trypsin inhibitor heavy chain H2,Inter-alpha-trypsin inhibitor heavy chain H2 |
| UniprotKB Entry Name | ITIH2_HUMAN,ITIH2_HUMAN |
| Fluid | Serum,Serum |
| M/Z | 990.56106,990.56106 |
| Charge | 1,NA |
| Mass (in Da) | NA,991.5698108 |
| fdr | NA,NA |
| Profiling Technique | LC-MS,LC-MS |
| Peptide Identification technique | LC-MS-MS/MS,LC-MS/MS |
| Quantification Technique | LC-ESI-MS,NA |
| Labelled/Label Free | Label Free,Label Free |
| FDR | NA,FDR 1 % |
| CancerPDF_ID | CancerPDF_ID1768, CancerPDF_ID11241, |
| p-Value | NA,NA |
| Software | MASCOT(v. 2.2.01),SEQUEST and Maxquant |
| Length | 9,9 |
| Cancer Type | Colorectal cancer,Melanoma |
| Database | SwissProt Database,SwissProt Database |
| Modification | NA,NA |
| Number of Patients | 30 patients and 30 healthy controls,8 cancer samples and 4 healthy samples |
| Regulation | NA,"Present in 3 cancer samples out of 8 cancer samples. ,Present in 2 healthy samples out of 4 healthy samples." |
| Validation | Leave One out Cross validation,na |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | NA |
| IEDB | |